Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-26 @ 11:22 AM
Study NCT ID:
NCT01008059
Status:
COMPLETED
Last Update Posted:
2019-05-17
First Post:
2009-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alfentanil: Simultaneous Testing Pilot
Sponsor:
Washington University School of Medicine
Organization:
Study Overview
Official Title:
Novel Noninvasive Assessment of Cytochrome P4450 Activity: Simultaneous Testing Pilot
Status:
COMPLETED
Status Verified Date:
2019-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate two paradigms for simultaneous assessment of hepatic and intestinal CYP3A activity.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 5R01GM063674-07 | NIH | None | https://reporter.nih.gov/quic… | View |